Efficacy and safety of nivolumab for advanced gastric cancer patients with poor performance statuses | BMC Cancer | Full Text

Efficacy and safety of nivolumab for advanced gastric cancer patients with poor performance statuses | BMC Cancer | Full Text

Efficacy and safety of nivolumab for advanced gastric cancer patients with poor performance statuses

Nivolumab has changed the treatment of advanced gastric cancer (AGC). Nivolumab shows better outcomes compared to best supportive care among AGC patients who received at least two prior regimens. However, ther...

Authors:Toshihiko Matsumoto, Yosuke Yamamoto, Yusuke Kuriona, Ukyo Okazaki, Shogo Kimura, Kou Miura, Takao Tsuduki, Takanori Watanabe, Yusuke Mastumoto and Masahiro Takatani

Citation:BMC Cancer 2020 20:684

Content type:Research article

 

Published on: 22 July 2020

• ViewFull Text
 
• ViewPDF